NOT KNOWN FACTUAL STATEMENTS ABOUT SAQUINAVIR MESYLATE

ACE inhibitors protect against angiotensin I from converting to angiotensin II, ARBS prevent the binding of angiotensin II onto blood vessel receptorsA randomized, double-blind, placebo-managed, single and various ascending dose Period 1 research to ascertain the safety, pharmacokinetics and meals and faecal microbiome outcomes of ibezapolstat admi